+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate



Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate



Hepatology 7(5): 810-815



Endoscopic injection sclerotherapy was given to 155 patients with esophageal varices mainly related to non-alcoholic liver cirrhosis. The formation of a superficial ulcer in the lower esophagus was achieved in 141 (91.0%) of the 155 patients, with an average of 4.1 sessions of endoscopic injection sclerotherapy during an average time of 4.9 weeks. The average volume of 5% ethanolamine oleate sclerosant used was 24.8, 19.2, 12.3 and 6.5 ml for the initial to fourth sessions of endoscopic injection sclerotherapy, respectively. For 14 patients, a sufficient number of seassions of endoscopic injection sclerotherapy could not be given: 10 early deaths (5 hepatoma, 4 liver failure and 1 gastric bleeding), and 4 refused further sessions. When the esophageal mucosa had been eliminated and a superficial ulcer had formed, episodes of recurrent bleeding or recurrence of esophageal varices were nil over a median follow-up of 14.6 months, with a range of 1 to 27 months. In seven patients, bleeding recurred before elimination of the mucosa could be achieved, but these bleeding episodes were well controlled with an additional session of endoscopic injection sclerotherapy. At the time of analysis, there were 36 deaths (20 hepatoma, 14 liver failure and 2 gastric bleeding) among these 155 patients. Thus, the mean follow-up was 16.3 months (range: 7 to 27 months) in the 119 survivors, with no recurrence of the varices. We propose that removal of the esophageal mucosa may well be the endpoint of repeated endoscopic injection sclerotherapy in the management of patients on injection sclerotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 006181084

Download citation: RISBibTeXText

PMID: 3498673

DOI: 10.1002/hep.1840070503


Related references

Esophageal stricture due to endoscopic injection sclerotherapy for esophageal varices using 5 percent ethanolamine oleate. Gastroenterological Endoscopy 31(4): 831-836, 1989

Studies on various esophageal lesions due to paravariceal injections of 5 percent ethanolamine oleate during endoscopic injection sclerotherapy of esophageal varices. Gastroenterological Endoscopy 28(10): 2257-2267, 1986

Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Hepato-Gastroenterology 34(1): 19-23, 1987

Injection sclerotherapy of esophageal varices using ethanolamine oleate. American Journal of Surgery 143(4): 426-431, 1982

Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices. Endoscopy 21(1): 50, 1989

Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices. Archives of Surgery 120(7): 833-836, 1985

Complete eradication of duodenal varices after endoscopic injection sclerotherapy with ethanolamine oleate: a case report. Gastrointestinal Endoscopy 67(4): 759-762, 2008

Endoscopic injection sclerotherapy with ethanolamine oleate with iopamidol for esophagojejunal varices in idiopathic portal hypertension. Digestive Diseases and Sciences 54(7): 1592-1596, 2009

Endoscopic sclerotherapy (ethanolamine oleate injection) for acute rectal varices bleeding in a patient with liver cirrhosis. Hepato-Gastroenterology 49(46): 941-943, 2002

Hemorrhagic duodenal varices treated successfully with endoscopic injection sclerotherapy using cyanoacrylate and ethanolamine-oleate: a case report. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 19(6): E233-E236, 2009

Recurrence and retreatment of esophageal varices after endoscopic injection sclerotherapy eis. Gastroenterological Endoscopy 33(4): 688-692, 1991

A comparison between endoscopic injection of bleeding esophageal varices using ethanolamine oleate and fibrin glue sealant in patients with bilharzial liver fibrosis. Endoscopy 31(5): 405, 1999

Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices. Gastrointestinal Endoscopy 51(5): 573-576, 2000

Removal of mucosa prevents recurrence of esophageal varices after endoscopic injection sclerotherapy. Gastroenterology 92(5 Part 2): 1469, 1987

Complete eradication by endoscopic injection sclerotherapy reduces the recurrence of esophageal varices. Nihon Shokakibyo Gakkai Zasshi 91(10): 1921-1928, 1994